Testimonial: Ahmad Abou Tayoun
)
Dr Ahmad Abou Tayoun is focused on improving diagnosis for patients with rare diseases in the Middle East. Find out how he has uncovered 10% more potential diagnoses, changing the face of clinical genetic testing.
Dr Ahmad Abou Tayoun is focused on improving diagnosis for patients with rare diseases in the Middle East. Find out how he has uncovered 10% more potential diagnoses, changing the face of clinical genetic testing.
© 2008 - 2023 Oxford Nanopore Technologies plc. All rights reserved. 登記された事務所:Gosling Building,\n Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK {'|'} 登記番号:05386273 {'|'} VAT番号:336942382。Oxford\n Nanopore Technologies、Wheel icon、EPI2ME、Flongle、GridION、Metrichor、MinION、MinIT、MinKNOW、Plongle、\n PromethION、SmidgION、UbikおよびVolTRAXは様々な国で登録されたOxford Nanopore Technologies\nの商標です。Oxford Nanopore Technologies製品は、\n現在すべて研究用です。